glp 1 menopause Interaction between GLP-1 Inhibitors and oral hormones GLP-1 and Menopause: Managing Weight

If youre tired of battling fatigue, brain fog, or low mood, its time to take a proactive step toward revitalization

This product contains glutathione in its reduced form, which is the most active and potent form of the antioxidant

Transitioning from weight loss to maintenance Determining goal weight achievement: Lost 10-12% body weight (cagrilintide alone) Lost 15-25% body weight (CagriSema) Weight stable for 4-8 weeks Satisfied with current weight Ready to focus on maintenance Maintenance dose options comparison: Option 1: Continue same dose Keep cagrilintide at 2.4mg weekly Ensures no regain Most conservative approach Highest cost Option 2: Reduce dose slightly Decrease to 1.8-2.0mg weekly Monitor weight for 4 weeks If stable, maintain If gaining, increase back 20-25% cost savings Option 3: Try every 10 days Instead of weekly, inject every 10 days Effectively 30% dose reduction Some maintain weight this way Requires close monitoring Recommendation: Try Option 2 first (reduce to 1.8-2.0mg)

Thymosin Beta 4 plays crucial roles in wound healing, cell migration, and tissue regeneration throughout the body

Nausea after a GLP-1 injection can typically start within the first 24-48 hours after the first dose or shortly after an increased dose

Regular appointments are also crucial